625 related articles for article (PubMed ID: 9815927)
41. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
Balaian L; Ball ED
Exp Hematol; 2005 Feb; 33(2):199-211. PubMed ID: 15676214
[TBL] [Abstract][Full Text] [Related]
42. Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils.
van der Kolk LE; de Haas M; Grillo-López AJ; Baars JW; van Oers MH
Leukemia; 2002 Apr; 16(4):693-9. PubMed ID: 11960351
[TBL] [Abstract][Full Text] [Related]
43. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
44. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
Niitsu N; Hayama M; Okamoto M; Khori M; Higashihara M; Tamaru J; Hirano M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4077-82. PubMed ID: 15217942
[TBL] [Abstract][Full Text] [Related]
45. Fc gamma R-mediated killing by eosinophils.
Graziano RF; Looney RJ; Shen L; Fanger MW
J Immunol; 1989 Jan; 142(1):230-5. PubMed ID: 2521234
[TBL] [Abstract][Full Text] [Related]
46. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
47. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
48. Expression of IgG Fc receptors in myeloid leukemic cell lines. Effect of colony-stimulating factors and cytokines.
Liesveld JL; Abboud CN; Looney RJ; Ryan DH; Brennan JK
J Immunol; 1988 Mar; 140(5):1527-33. PubMed ID: 2964478
[TBL] [Abstract][Full Text] [Related]
49. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
Nguyen DH; Ball ED; Varki A
Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
[TBL] [Abstract][Full Text] [Related]
50. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
[TBL] [Abstract][Full Text] [Related]
51. Effect of cisplatin treatment of human monocyte cell line U937 on the induction of tumoricidal activity.
Singh RK; Singh SM; Sodhi A
Neoplasma; 1992; 39(3):137-40. PubMed ID: 1528316
[TBL] [Abstract][Full Text] [Related]
52. Granulocyte colony-stimulating factor in acute myeloid leukemia.
Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
[TBL] [Abstract][Full Text] [Related]
53. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
Baldwin GC; Chung GY; Kaslander C; Esmail T; Reisfeld RA; Golde DW
Br J Haematol; 1993 Apr; 83(4):545-53. PubMed ID: 7686031
[TBL] [Abstract][Full Text] [Related]
54. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).
van Egmond M; van Spriel AB; Vermeulen H; Huls G; van Garderen E; van de Winkel JG
Cancer Res; 2001 May; 61(10):4055-60. PubMed ID: 11358825
[TBL] [Abstract][Full Text] [Related]
55. Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells.
Silla LM; Chen J; Zhong RK; Whiteside TL; Ball ED
Br J Haematol; 1995 Apr; 89(4):712-8. PubMed ID: 7772507
[TBL] [Abstract][Full Text] [Related]
56. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
57. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells.
Vitale C; Romagnani C; Puccetti A; Olive D; Costello R; Chiossone L; Pitto A; Bacigalupo A; Moretta L; Mingari MC
Proc Natl Acad Sci U S A; 2001 May; 98(10):5764-9. PubMed ID: 11320212
[TBL] [Abstract][Full Text] [Related]
58. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
59. Combination of interleukin-2-stimulated lymphocytes and bispecific antibodies that efficiently lyse leukemic cells does not affect bone marrow CD34-positive stem cell function in vitro.
Kaneko T; Fukuda J; Teramura M; Fusauchi Y; Kakui Y; Okumura K; Mizoguchi H; Oshimi K
Bone Marrow Transplant; 1994 Aug; 14(2):213-7. PubMed ID: 7527685
[TBL] [Abstract][Full Text] [Related]
60. Cell cycle specific effects of tumor necrosis factor alpha in monocyte mediated leukemic cell death and the role of beta 2-integrins.
van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Langenhuijsen MM
Cancer Res; 1993 Sep; 53(18):4399-407. PubMed ID: 7689934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
